BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. Pediatric Anesthesia 2009;19:364-70. [DOI: 10.1111/j.1460-9592.2008.02905.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Kozek-langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC, Fries D, Görlinger K, Haas T, Imberger G, Jacob M, Lancé M, Llau J, Mallett S, Meier J, Rahe-meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelsø AJ, Wouters P, Wyffels P. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology 2013;30:270-382. [DOI: 10.1097/eja.0b013e32835f4d5b] [Cited by in Crossref: 553] [Cited by in F6Publishing: 133] [Article Influence: 61.4] [Reference Citation Analysis]
2 Guzzetta NA, Russell IA, Williams GD. Review of the Off-Label Use of Recombinant Activated Factor VII in Pediatric Cardiac Surgery Patients. Anesthesia & Analgesia 2012;115:364-78. [DOI: 10.1213/ane.0b013e31825aff10] [Cited by in Crossref: 44] [Cited by in F6Publishing: 5] [Article Influence: 4.4] [Reference Citation Analysis]
3 Guzzetta NA. Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery: RED BLOOD CELL TRANSFUSION IN PEDIATRIC CARDIAC PATIENTS. Pediatric Anesthesia 2011;21:504-11. [DOI: 10.1111/j.1460-9592.2010.03464.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
4 Giglia TM, Massicotte MP, Tweddell JS, Barst RJ, Bauman M, Erickson CC, Feltes TF, Foster E, Hinoki K, Ichord RN, Kreutzer J, Mccrindle BW, Newburger JW, Tabbutt S, Todd JL, Webb CL. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation 2013;128:2622-703. [DOI: 10.1161/01.cir.0000436140.77832.7a] [Cited by in Crossref: 162] [Cited by in F6Publishing: 118] [Article Influence: 18.0] [Reference Citation Analysis]
5 Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N. Predicting Response to rFVIIa in Neonates With Intractable Bleeding or Severe Coagulation Disturbances. Journal of Pediatric Hematology/Oncology 2013;35:221-6. [DOI: 10.1097/mph.0b013e318286d27e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M. Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. J Perinatol 2011;31:188-92. [PMID: 20671714 DOI: 10.1038/jp.2010.85] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
7 Okonta KE, Edwin F, Falase B. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? Interact Cardiovasc Thorac Surg 2012;15:690-4. [PMID: 22811512 DOI: 10.1093/icvts/ivs309] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
8 Hong I, Stachnik J. Unlabeled uses of factor VIIa (recombinant) in pediatric patients. American Journal of Health-System Pharmacy 2010;67:1909-19. [DOI: 10.2146/ajhp090667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Repessé X, Au SM, Bréchot N, Trouillet JL, Leprince P, Chastre J, Combes A, Luyt CE. Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review. Crit Care 2013;17:R55. [PMID: 23531278 DOI: 10.1186/cc12581] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
10 Goobie SM, Haas T. Perioperative bleeding management in pediatric patients. Curr Opin Anaesthesiol 2016;29:352-8. [PMID: 26844864 DOI: 10.1097/ACO.0000000000000308] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
11 Rigby M, Kamat P, Vats A, Heard M. Controlling intrathoracic hemorrhage on ECMO: help from Factor VIIa and Virchow. Perfusion 2013;28:201-6. [DOI: 10.1177/0267659112469549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Guzzetta NA, Miller BE. Principles of hemostasis in children: models and maturation: Principles of hemostasis in children. Pediatric Anesthesia 2011;21:3-9. [DOI: 10.1111/j.1460-9592.2010.03410.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
13 Pychyńska-pokorska M, Pągowska-klimek I, Krajewski W, Moll JJ. Use of Recombinant Activated Factor VII for Controlling Refractory Postoperative Bleeding in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass. Journal of Cardiothoracic and Vascular Anesthesia 2011;25:987-94. [DOI: 10.1053/j.jvca.2011.05.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
14 Long M, Wagner D, Maslach-hubbard A, Pasko D, Baldridge P, Annich G. Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review. Perfusion 2014;29:163-70. [DOI: 10.1177/0267659113499782] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
15 Dinardo JA, Shukla AC, Mcgowan FX. Anesthesia for Congenital Heart Surgery. Smith's Anesthesia for Infants and Children. Elsevier; 2011. pp. 605-73. [DOI: 10.1016/b978-0-323-06612-9.00020-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Downey L, Brown ML, Faraoni D, Zurakowski D, DiNardo JA. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients. Anesth Analg 2017;124:1431-6. [PMID: 28319507 DOI: 10.1213/ANE.0000000000001947] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 4.6] [Reference Citation Analysis]
17 Smith AH, Gay JC, Patel NR. Trends in resource utilization associated with the inpatient treatment of neonatal congenital heart disease. Congenit Heart Dis 2014;9:96-105. [PMID: 23734574 DOI: 10.1111/chd.12103] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
18 Icheva V, Nowak-machen M, Budde U, Jaschonek K, Neunhoeffer F, Kumpf M, Hofbeck M, Schlensak C, Wiegand G. Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series. J Thromb Haemost 2018;16:2150-8. [DOI: 10.1111/jth.14208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
19 Eaton MP, Iannoli EM. Coagulation considerations for infants and children undergoing cardiopulmonary bypass: Coagulation in children on bypass. Pediatric Anesthesia 2011;21:31-42. [DOI: 10.1111/j.1460-9592.2010.03467.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
20 Rice NT, Szlam F, Varner JD, Bernstein PS, Szlam AD, Tanaka KA. Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples. PLoS One 2016;11:e0154127. [PMID: 27196067 DOI: 10.1371/journal.pone.0154127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
21 Brand A. Blood transfusions in neonatal cardiac surgery and ECMO. ISBT Science Series 2009;4:208-15. [DOI: 10.1111/j.1751-2824.2009.01240.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Scott JP. Recombinant activated factor seven in pediatric cardiac surgery-does thrombotic risk outweigh hemostatic benefit? Transl Pediatr 2019;8:465-7. [PMID: 31993363 DOI: 10.21037/tp.2019.10.04] [Reference Citation Analysis]
23 Faust K, Tröger B, Kahl F, Schumacher M, Göpel W, Härtel C. Successful use of recombinant factor VIIa in a preterm infant with life-threatening haematuria. Blood Coagulation & Fibrinolysis 2009;20:601-4. [DOI: 10.1097/mbc.0b013e32832f6c40] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Maxwell LG, Goodwin SR, Mancuso TJ, Baum VC, Zuckerberg AL, Morgan PG, Motoyama EK, Davis PJ, Sullivan KJ. Systemic Disorders. Smith's Anesthesia for Infants and Children. Elsevier; 2011. pp. 1098-182. [DOI: 10.1016/b978-0-323-06612-9.00036-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]